ASH Medical Educators Institute: A View From the Classroom
Dr. Laura Michaelis interviews Drs. Molly Mandernach and Annie Im about their experience participating in the ASH Medical Educators Institute.
Surround and Protect! Expression of PD-L1 on Tumor-Associated Macrophages in Classic Hodgkin Lymphoma
Dr. Kim looks at two studies that reaffirm the association between high macrophage counts and poor response to several traditional chemotherapy regimens, and remarkable res
Drs. Hillard Lazarus and Per Ljungman discuss the optimal approach to prevent CMV infection in patients undergoing AHCT in 2018.
Dr. Kim studies the association between high macrophage count and poor response to traditional chemotherapy, but remarkable response to PD-L1-directed immunotherapy in relapsed/refractory cHL.
Drs. Theresa Coetzer and Eduardo Rego discuss ASH global initiatives and the impact they have on international hematologists and their patients.
March/April 2018Volume 15, Issue 2
View all Features articles
View all Diffusion articles
Dr. Thompson provides an overview of ASH global initiatives and the Society's global reach.
View all president's column articles
View all Ask the Hematologist articles
View all Clinical Trials Corner articles
View all Mini Review articles
Senators Tim Scott (R-SC) and Cory Booker (D-NJ) introduced the Sickle Cell Disease Surveillance, Prevention, and Treatment Act of 2018.
On December 20, the House of Representatives and the Senate voted to approve H.R. 1, tax reform legislation. Select members of each chamber came together to resolve disagreements between the two versions passed by the House and Senate.
Congress spent much of 2017 focused on the repeal and replace of the Affordable Care Act (ACA). Included is a summary of Congress and the Administration’s actions on repeal and replace of the ACA that occurred in 2017.
ASH continues to increase its efforts to expand and enhance the Society’s reach. NIH funding, efforts to ensure patient access to drugs, and sickle cell disease were top priorities on ASH’s advocacy agenda in 2017.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology